

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 5.80845538 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.80845538 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 5.65820365 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.65820365 |
| 5 | lysine catabolic process (GO:0006554) | 5.43517737 |
| 6 | lysine metabolic process (GO:0006553) | 5.43517737 |
| 7 | tricarboxylic acid cycle (GO:0006099) | 5.31931668 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 5.27957492 |
| 9 | 2-oxoglutarate metabolic process (GO:0006103) | 5.22107055 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.21825243 |
| 11 | glyoxylate metabolic process (GO:0046487) | 5.03057127 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 5.00450334 |
| 13 | tryptophan catabolic process (GO:0006569) | 5.00450334 |
| 14 | indole-containing compound catabolic process (GO:0042436) | 5.00450334 |
| 15 | oxaloacetate metabolic process (GO:0006107) | 4.96349160 |
| 16 | cellular ketone body metabolic process (GO:0046950) | 4.86933464 |
| 17 | tryptophan metabolic process (GO:0006568) | 4.84468889 |
| 18 | NADH metabolic process (GO:0006734) | 4.79242579 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 4.78688977 |
| 20 | behavioral response to nicotine (GO:0035095) | 4.76101468 |
| 21 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.66227154 |
| 22 | bile acid biosynthetic process (GO:0006699) | 4.47839991 |
| 23 | valine metabolic process (GO:0006573) | 4.43220193 |
| 24 | aspartate family amino acid catabolic process (GO:0009068) | 4.34814040 |
| 25 | regulation of triglyceride catabolic process (GO:0010896) | 4.32428312 |
| 26 | branched-chain amino acid catabolic process (GO:0009083) | 4.25279717 |
| 27 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.18851408 |
| 28 | succinate metabolic process (GO:0006105) | 4.18157590 |
| 29 | ketone body metabolic process (GO:1902224) | 4.18141578 |
| 30 | ubiquinone biosynthetic process (GO:0006744) | 4.18071624 |
| 31 | cysteine metabolic process (GO:0006534) | 4.15488206 |
| 32 | fatty acid beta-oxidation (GO:0006635) | 4.12747732 |
| 33 | sulfur amino acid catabolic process (GO:0000098) | 4.11568198 |
| 34 | alpha-amino acid catabolic process (GO:1901606) | 4.10381929 |
| 35 | amino-acid betaine metabolic process (GO:0006577) | 4.07454891 |
| 36 | regulation of protein activation cascade (GO:2000257) | 4.01945917 |
| 37 | negative regulation of fibrinolysis (GO:0051918) | 4.01439640 |
| 38 | serine family amino acid catabolic process (GO:0009071) | 3.98371571 |
| 39 | short-chain fatty acid metabolic process (GO:0046459) | 3.97428095 |
| 40 | acetyl-CoA metabolic process (GO:0006084) | 3.92317348 |
| 41 | aromatic amino acid family metabolic process (GO:0009072) | 3.90349325 |
| 42 | ethanol oxidation (GO:0006069) | 3.90123189 |
| 43 | urea metabolic process (GO:0019627) | 3.89470737 |
| 44 | urea cycle (GO:0000050) | 3.89470737 |
| 45 | high-density lipoprotein particle remodeling (GO:0034375) | 3.89307140 |
| 46 | homocysteine metabolic process (GO:0050667) | 3.89142547 |
| 47 | branched-chain amino acid metabolic process (GO:0009081) | 3.87618980 |
| 48 | complement activation, alternative pathway (GO:0006957) | 3.86666465 |
| 49 | fatty acid catabolic process (GO:0009062) | 3.85345294 |
| 50 | coenzyme catabolic process (GO:0009109) | 3.81393605 |
| 51 | cellular amino acid catabolic process (GO:0009063) | 3.79815435 |
| 52 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.79489403 |
| 53 | regulation of complement activation (GO:0030449) | 3.79335206 |
| 54 | tricarboxylic acid metabolic process (GO:0072350) | 3.76641846 |
| 55 | fatty acid oxidation (GO:0019395) | 3.75375860 |
| 56 | fatty acid transmembrane transport (GO:1902001) | 3.74841947 |
| 57 | oxidative phosphorylation (GO:0006119) | 3.74355333 |
| 58 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.73925119 |
| 59 | regulation of fibrinolysis (GO:0051917) | 3.73545431 |
| 60 | ubiquinone metabolic process (GO:0006743) | 3.73350761 |
| 61 | glycine metabolic process (GO:0006544) | 3.73258537 |
| 62 | carnitine shuttle (GO:0006853) | 3.71411926 |
| 63 | monocarboxylic acid catabolic process (GO:0072329) | 3.69017021 |
| 64 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.68800278 |
| 65 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.68800278 |
| 66 | NADH dehydrogenase complex assembly (GO:0010257) | 3.68800278 |
| 67 | bile acid metabolic process (GO:0008206) | 3.67967771 |
| 68 | protein complex biogenesis (GO:0070271) | 3.67604356 |
| 69 | lipid oxidation (GO:0034440) | 3.66907652 |
| 70 | NAD metabolic process (GO:0019674) | 3.65749198 |
| 71 | respiratory chain complex IV assembly (GO:0008535) | 3.64588611 |
| 72 | tyrosine metabolic process (GO:0006570) | 3.60543141 |
| 73 | quinone biosynthetic process (GO:1901663) | 3.59880564 |
| 74 | organic acid catabolic process (GO:0016054) | 3.57756223 |
| 75 | carboxylic acid catabolic process (GO:0046395) | 3.57756223 |
| 76 | cellular modified amino acid catabolic process (GO:0042219) | 3.57287511 |
| 77 | negative regulation of telomere maintenance (GO:0032205) | 3.55725354 |
| 78 | indolalkylamine metabolic process (GO:0006586) | 3.53142865 |
| 79 | nitrogen cycle metabolic process (GO:0071941) | 3.51484492 |
| 80 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.50282211 |
| 81 | biotin metabolic process (GO:0006768) | 3.50108724 |
| 82 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.47974007 |
| 83 | protein carboxylation (GO:0018214) | 3.47974007 |
| 84 | regulation of skeletal muscle contraction (GO:0014819) | 3.47571588 |
| 85 | axoneme assembly (GO:0035082) | 3.45836923 |
| 86 | acylglycerol homeostasis (GO:0055090) | 3.43833118 |
| 87 | triglyceride homeostasis (GO:0070328) | 3.43833118 |
| 88 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.40688729 |
| 89 | carnitine metabolic process (GO:0009437) | 3.39968012 |
| 90 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.37432515 |
| 91 | serine family amino acid metabolic process (GO:0009069) | 3.36767443 |
| 92 | regulation of cholesterol esterification (GO:0010872) | 3.36311880 |
| 93 | reverse cholesterol transport (GO:0043691) | 3.36271223 |
| 94 | cytochrome complex assembly (GO:0017004) | 3.35517437 |
| 95 | glutamate metabolic process (GO:0006536) | 3.34419451 |
| 96 | aldehyde catabolic process (GO:0046185) | 3.33704997 |
| 97 | S-adenosylmethionine metabolic process (GO:0046500) | 3.32385674 |
| 98 | plasma lipoprotein particle remodeling (GO:0034369) | 3.29460295 |
| 99 | protein-lipid complex remodeling (GO:0034368) | 3.29460295 |
| 100 | macromolecular complex remodeling (GO:0034367) | 3.29460295 |
| 101 | dicarboxylic acid metabolic process (GO:0043648) | 3.26113297 |
| 102 | cellular biogenic amine catabolic process (GO:0042402) | 3.25943114 |
| 103 | amine catabolic process (GO:0009310) | 3.25943114 |
| 104 | phospholipid homeostasis (GO:0055091) | 3.24718199 |
| 105 | serine family amino acid biosynthetic process (GO:0009070) | 3.22249310 |
| 106 | regulation of fatty acid oxidation (GO:0046320) | 3.21944319 |
| 107 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.21739576 |
| 108 | benzene-containing compound metabolic process (GO:0042537) | 3.21512345 |
| 109 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.20190282 |
| 110 | negative regulation of sterol transport (GO:0032372) | 3.18815649 |
| 111 | negative regulation of cholesterol transport (GO:0032375) | 3.18815649 |
| 112 | regulation of coenzyme metabolic process (GO:0051196) | 3.16187102 |
| 113 | regulation of cofactor metabolic process (GO:0051193) | 3.16187102 |
| 114 | L-fucose catabolic process (GO:0042355) | 3.15279944 |
| 115 | fucose catabolic process (GO:0019317) | 3.15279944 |
| 116 | L-fucose metabolic process (GO:0042354) | 3.15279944 |
| 117 | epithelial cilium movement (GO:0003351) | 3.14133864 |
| 118 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.13887753 |
| 119 | DNA deamination (GO:0045006) | 3.07897049 |
| 120 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.07416971 |
| 121 | neuronal action potential (GO:0019228) | 3.07236304 |
| 122 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.07050427 |
| 123 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.05931272 |
| 124 | L-methionine salvage (GO:0071267) | 3.05221908 |
| 125 | L-methionine biosynthetic process (GO:0071265) | 3.05221908 |
| 126 | amino acid salvage (GO:0043102) | 3.05221908 |
| 127 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.04512643 |
| 128 | mannosylation (GO:0097502) | 3.03767109 |
| 129 | cofactor catabolic process (GO:0051187) | 3.03663008 |
| 130 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.02681874 |
| 131 | indole-containing compound metabolic process (GO:0042430) | 2.99832072 |
| 132 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.99352336 |
| 133 | protein-cofactor linkage (GO:0018065) | 2.96155700 |
| 134 | rRNA catabolic process (GO:0016075) | 2.94306166 |
| 135 | drug catabolic process (GO:0042737) | 2.94239714 |
| 136 | exogenous drug catabolic process (GO:0042738) | 2.93485209 |
| 137 | primary amino compound metabolic process (GO:1901160) | 2.92912237 |
| 138 | response to pheromone (GO:0019236) | 2.90308396 |
| 139 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.82953068 |
| 140 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.82123703 |
| 141 | detection of light stimulus involved in visual perception (GO:0050908) | 2.82123703 |
| 142 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.80262095 |
| 143 | protein polyglutamylation (GO:0018095) | 2.79656484 |
| 144 | auditory receptor cell stereocilium organization (GO:0060088) | 2.78072474 |
| 145 | serotonin metabolic process (GO:0042428) | 2.74529684 |
| 146 | inositol phosphate catabolic process (GO:0071545) | 2.69390322 |
| 147 | regulation of hexokinase activity (GO:1903299) | 2.67059322 |
| 148 | regulation of glucokinase activity (GO:0033131) | 2.67059322 |
| 149 | cilium movement (GO:0003341) | 2.63973671 |
| 150 | methionine biosynthetic process (GO:0009086) | 2.62196587 |
| 151 | positive regulation of fatty acid transport (GO:2000193) | 2.61093746 |
| 152 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.60382785 |
| 153 | quinone metabolic process (GO:1901661) | 2.54137035 |
| 154 | inositol phosphate dephosphorylation (GO:0046855) | 2.53688833 |
| 155 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.53688833 |
| 156 | adenosine metabolic process (GO:0046085) | 2.53428195 |
| 157 | regulation of relaxation of muscle (GO:1901077) | 2.52789685 |
| 158 | dopamine transport (GO:0015872) | 2.50568462 |
| 159 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.50421940 |
| 160 | membrane depolarization during action potential (GO:0086010) | 2.49343656 |
| 161 | NAD biosynthetic process (GO:0009435) | 2.49136835 |
| 162 | regulation of cilium movement (GO:0003352) | 2.48083250 |
| 163 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.47432482 |
| 164 | photoreceptor cell maintenance (GO:0045494) | 2.46934206 |
| 165 | rhodopsin mediated signaling pathway (GO:0016056) | 2.45100238 |
| 166 | retinal cone cell development (GO:0046549) | 2.44883845 |
| 167 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.43590568 |
| 168 | regulation of action potential (GO:0098900) | 2.41477289 |
| 169 | action potential (GO:0001508) | 2.41039782 |
| 170 | oxidative demethylation (GO:0070989) | 2.40311453 |
| 171 | synaptic transmission, cholinergic (GO:0007271) | 2.37902353 |
| 172 | alkaloid metabolic process (GO:0009820) | 2.37360198 |
| 173 | protein K11-linked deubiquitination (GO:0035871) | 2.37208344 |
| 174 | polyol catabolic process (GO:0046174) | 2.36620487 |
| 175 | gamma-aminobutyric acid transport (GO:0015812) | 2.36129594 |
| 176 | electron transport chain (GO:0022900) | 2.36027311 |
| 177 | arginine metabolic process (GO:0006525) | 2.35758168 |
| 178 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.35251161 |
| 179 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.35251161 |
| 180 | behavioral response to ethanol (GO:0048149) | 2.34318115 |
| 181 | estrogen biosynthetic process (GO:0006703) | 2.33202963 |
| 182 | thyroid hormone metabolic process (GO:0042403) | 2.31980603 |
| 183 | base-excision repair, AP site formation (GO:0006285) | 2.31770838 |
| 184 | neuronal action potential propagation (GO:0019227) | 2.31675520 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.38357021 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.29312312 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.13784664 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.56436856 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.78344628 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.62765292 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.48418694 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.29996870 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.69442264 |
| 10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.52265289 |
| 11 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.20443342 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 3.10090234 |
| 13 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.03486901 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.98871776 |
| 15 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.93313940 |
| 16 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.85593511 |
| 17 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.79524764 |
| 18 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.72664672 |
| 19 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.37610280 |
| 20 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.28136152 |
| 21 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.28134584 |
| 22 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.26175305 |
| 23 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.24758819 |
| 24 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.21322803 |
| 25 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.16237769 |
| 26 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.16033473 |
| 27 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.13514067 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 2.08440117 |
| 29 | FUS_26573619_Chip-Seq_HEK293_Human | 2.03969844 |
| 30 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.01405403 |
| 31 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.99882119 |
| 32 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.98171586 |
| 33 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.93837238 |
| 34 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.92346148 |
| 35 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.87344131 |
| 36 | EWS_26573619_Chip-Seq_HEK293_Human | 1.85604986 |
| 37 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.84604652 |
| 38 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.80954956 |
| 39 | * EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.76416219 |
| 40 | P300_19829295_ChIP-Seq_ESCs_Human | 1.75663921 |
| 41 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.74901419 |
| 42 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.73466210 |
| 43 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.65078254 |
| 44 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.62265488 |
| 45 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.60218308 |
| 46 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.58964087 |
| 47 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.55495527 |
| 48 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.50219778 |
| 49 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.45463834 |
| 50 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.45381185 |
| 51 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.45381185 |
| 52 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.44957342 |
| 53 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43017101 |
| 54 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.42465650 |
| 55 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.40209501 |
| 56 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.39874398 |
| 57 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.39486824 |
| 58 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.39081385 |
| 59 | TCF4_23295773_ChIP-Seq_U87_Human | 1.38539426 |
| 60 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.38399132 |
| 61 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.37922963 |
| 62 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.37922963 |
| 63 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.36988092 |
| 64 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.36922894 |
| 65 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.36922894 |
| 66 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.35501512 |
| 67 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.35379203 |
| 68 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34863395 |
| 69 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.34837885 |
| 70 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.34455530 |
| 71 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.33120348 |
| 72 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.32479200 |
| 73 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.31796150 |
| 74 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.30171395 |
| 75 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.30079289 |
| 76 | AR_25329375_ChIP-Seq_VCAP_Human | 1.29628925 |
| 77 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.29297028 |
| 78 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.28669496 |
| 79 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.27630619 |
| 80 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.26254403 |
| 81 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.24833703 |
| 82 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.24806479 |
| 83 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.24739405 |
| 84 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.24719659 |
| 85 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.23785322 |
| 86 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.22266907 |
| 87 | NCOR_22424771_ChIP-Seq_293T_Human | 1.22063560 |
| 88 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.21166431 |
| 89 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.20660251 |
| 90 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.20289793 |
| 91 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.19508446 |
| 92 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.19424770 |
| 93 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.19080050 |
| 94 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.18983291 |
| 95 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.18882902 |
| 96 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.18531201 |
| 97 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18531201 |
| 98 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.18192933 |
| 99 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.17667004 |
| 100 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.16874334 |
| 101 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.15934458 |
| 102 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.15699304 |
| 103 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.15574501 |
| 104 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.14226351 |
| 105 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.13868141 |
| 106 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.13820696 |
| 107 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.13765907 |
| 108 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.11599251 |
| 109 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.11130372 |
| 110 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09757573 |
| 111 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.09172035 |
| 112 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.08542308 |
| 113 | * GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.08020750 |
| 114 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.07001461 |
| 115 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.06874613 |
| 116 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.06443716 |
| 117 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.06290961 |
| 118 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.05380255 |
| 119 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04993746 |
| 120 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.04198321 |
| 121 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.03346580 |
| 122 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.02596997 |
| 123 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.02477726 |
| 124 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.02095921 |
| 125 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.01972415 |
| 126 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.01354532 |
| 127 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.01006991 |
| 128 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00353622 |
| 129 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.00332865 |
| 130 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.00258629 |
| 131 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.99808344 |
| 132 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.99098870 |
| 133 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97809994 |
| 134 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.97778885 |
| 135 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.96916936 |
| 136 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.96488430 |
| 137 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.96154272 |
| 138 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.96002446 |
| 139 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.95205705 |
| 140 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.95152506 |
| 141 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.95073032 |
| 142 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.94884898 |
| 143 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.94862004 |
| 144 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.94692802 |
| 145 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.94508835 |
| 146 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.94407567 |
| 147 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.93820303 |
| 148 | AR_20517297_ChIP-Seq_VCAP_Human | 0.92642681 |
| 149 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.89385931 |
| 150 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88564998 |
| 151 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.88537960 |
| 152 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.88517608 |
| 153 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.86775071 |
| 154 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.83959708 |
| 155 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.83572293 |
| 156 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.81923096 |
| 157 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.78483819 |
| 158 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.78189978 |
| 159 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.76653042 |
| 160 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.76457631 |
| 161 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.72363957 |
| 162 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.72363957 |
| 163 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.71361181 |
| 164 | * VDR_23849224_ChIP-Seq_CD4+_Human | 0.70459709 |
| 165 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.70337149 |
| 166 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.69242179 |
| 167 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.68419383 |
| 168 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.68050338 |
| 169 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.67737274 |
| 170 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.67666041 |
| 171 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.67412290 |
| 172 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.66770943 |
| 173 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.66337957 |
| 174 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.66106827 |
| 175 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.66103642 |
| 176 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.65568190 |
| 177 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.65192107 |
| 178 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.63760974 |
| 179 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.63585810 |
| 180 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.62479111 |
| 181 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.62406624 |
| 182 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.62328152 |
| 183 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.61959861 |
| 184 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.60887815 |
| 185 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.60401352 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.47313406 |
| 2 | MP0005360_urolithiasis | 5.58429499 |
| 3 | MP0005365_abnormal_bile_salt | 5.42031081 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 5.02685256 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 5.00281844 |
| 6 | MP0002837_dystrophic_cardiac_calcinosis | 4.39414254 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.66532689 |
| 8 | MP0003646_muscle_fatigue | 3.41322237 |
| 9 | MP0010329_abnormal_lipoprotein_level | 2.94563273 |
| 10 | MP0003252_abnormal_bile_duct | 2.74710275 |
| 11 | MP0004084_abnormal_cardiac_muscle | 2.63509072 |
| 12 | MP0005332_abnormal_amino_acid | 2.52363121 |
| 13 | MP0006036_abnormal_mitochondrial_physio | 2.41791060 |
| 14 | MP0005083_abnormal_biliary_tract | 2.41733047 |
| 15 | MP0001968_abnormal_touch/_nociception | 2.37666714 |
| 16 | MP0009840_abnormal_foam_cell | 2.37293831 |
| 17 | MP0004043_abnormal_pH_regulation | 2.35030626 |
| 18 | MP0002638_abnormal_pupillary_reflex | 2.33851387 |
| 19 | MP0004215_abnormal_myocardial_fiber | 2.18885448 |
| 20 | MP0005551_abnormal_eye_electrophysiolog | 2.18348754 |
| 21 | MP0009697_abnormal_copulation | 2.17985409 |
| 22 | MP0004036_abnormal_muscle_relaxation | 2.13143731 |
| 23 | MP0005645_abnormal_hypothalamus_physiol | 2.09160185 |
| 24 | MP0008877_abnormal_DNA_methylation | 2.08228734 |
| 25 | MP0006035_abnormal_mitochondrial_morpho | 2.07931370 |
| 26 | MP0009046_muscle_twitch | 2.01983472 |
| 27 | MP0001666_abnormal_nutrient_absorption | 2.01773041 |
| 28 | MP0004130_abnormal_muscle_cell | 2.01678775 |
| 29 | MP0005319_abnormal_enzyme/_coenzyme | 2.00215217 |
| 30 | MP0000751_myopathy | 1.94989689 |
| 31 | MP0001986_abnormal_taste_sensitivity | 1.92131409 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.91099450 |
| 33 | MP0003195_calcinosis | 1.87483992 |
| 34 | MP0008872_abnormal_physiological_respon | 1.86423455 |
| 35 | MP0002118_abnormal_lipid_homeostasis | 1.79699630 |
| 36 | MP0003880_abnormal_central_pattern | 1.77034812 |
| 37 | MP0005330_cardiomyopathy | 1.76494924 |
| 38 | MP0000609_abnormal_liver_physiology | 1.74718559 |
| 39 | MP0006072_abnormal_retinal_apoptosis | 1.73786875 |
| 40 | MP0009745_abnormal_behavioral_response | 1.72472993 |
| 41 | MP0006292_abnormal_olfactory_placode | 1.70355805 |
| 42 | MP0002102_abnormal_ear_morphology | 1.66659113 |
| 43 | MP0001984_abnormal_olfaction | 1.64999652 |
| 44 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.64117966 |
| 45 | MP0001764_abnormal_homeostasis | 1.61486997 |
| 46 | MP0002272_abnormal_nervous_system | 1.61419162 |
| 47 | MP0000569_abnormal_digit_pigmentation | 1.61183780 |
| 48 | MP0004142_abnormal_muscle_tone | 1.60034671 |
| 49 | MP0002736_abnormal_nociception_after | 1.58287423 |
| 50 | MP0003787_abnormal_imprinting | 1.57950984 |
| 51 | MP0005253_abnormal_eye_physiology | 1.56489273 |
| 52 | MP0010386_abnormal_urinary_bladder | 1.55699154 |
| 53 | MP0006276_abnormal_autonomic_nervous | 1.55535866 |
| 54 | MP0000749_muscle_degeneration | 1.45023478 |
| 55 | MP0003868_abnormal_feces_composition | 1.43840188 |
| 56 | MP0005266_abnormal_metabolism | 1.42391552 |
| 57 | MP0000372_irregular_coat_pigmentation | 1.38122917 |
| 58 | MP0003186_abnormal_redox_activity | 1.35182672 |
| 59 | MP0004133_heterotaxia | 1.34980194 |
| 60 | MP0002972_abnormal_cardiac_muscle | 1.33082277 |
| 61 | MP0002234_abnormal_pharynx_morphology | 1.30450395 |
| 62 | MP0002269_muscular_atrophy | 1.28108312 |
| 63 | MP0003137_abnormal_impulse_conducting | 1.27791176 |
| 64 | MP0001486_abnormal_startle_reflex | 1.27577948 |
| 65 | MP0010368_abnormal_lymphatic_system | 1.26579655 |
| 66 | MP0002064_seizures | 1.25797148 |
| 67 | MP0005385_cardiovascular_system_phenoty | 1.23231551 |
| 68 | MP0001544_abnormal_cardiovascular_syste | 1.23231551 |
| 69 | MP0003136_yellow_coat_color | 1.18124012 |
| 70 | MP0002078_abnormal_glucose_homeostasis | 1.16628796 |
| 71 | MP0005167_abnormal_blood-brain_barrier | 1.14150529 |
| 72 | MP0000631_abnormal_neuroendocrine_gland | 1.13850318 |
| 73 | MP0005451_abnormal_body_composition | 1.13554964 |
| 74 | MP0005620_abnormal_muscle_contractility | 1.13078905 |
| 75 | MP0001485_abnormal_pinna_reflex | 1.11944744 |
| 76 | MP0003221_abnormal_cardiomyocyte_apopto | 1.11847183 |
| 77 | MP0001501_abnormal_sleep_pattern | 1.10698722 |
| 78 | MP0009643_abnormal_urine_homeostasis | 1.09953347 |
| 79 | MP0004087_abnormal_muscle_fiber | 1.07626263 |
| 80 | MP0002572_abnormal_emotion/affect_behav | 1.05258968 |
| 81 | MP0002733_abnormal_thermal_nociception | 1.04802368 |
| 82 | MP0000598_abnormal_liver_morphology | 1.03772094 |
| 83 | MP0002160_abnormal_reproductive_system | 1.02945206 |
| 84 | MP0008775_abnormal_heart_ventricle | 1.01602625 |
| 85 | MP0000427_abnormal_hair_cycle | 1.00759146 |
| 86 | MP0005174_abnormal_tail_pigmentation | 0.99391626 |
| 87 | MP0003656_abnormal_erythrocyte_physiolo | 0.99132809 |
| 88 | MP0005423_abnormal_somatic_nervous | 0.98889938 |
| 89 | MP0004019_abnormal_vitamin_homeostasis | 0.97510477 |
| 90 | MP0008995_early_reproductive_senescence | 0.97098157 |
| 91 | MP0002138_abnormal_hepatobiliary_system | 0.96252391 |
| 92 | MP0005376_homeostasis/metabolism_phenot | 0.95825251 |
| 93 | MP0002127_abnormal_cardiovascular_syste | 0.94779387 |
| 94 | MP0004924_abnormal_behavior | 0.94124927 |
| 95 | MP0005386_behavior/neurological_phenoty | 0.94124927 |
| 96 | MP0004085_abnormal_heartbeat | 0.93327409 |
| 97 | MP0010630_abnormal_cardiac_muscle | 0.93262017 |
| 98 | MP0001905_abnormal_dopamine_level | 0.92800646 |
| 99 | MP0001970_abnormal_pain_threshold | 0.92572575 |
| 100 | MP0005670_abnormal_white_adipose | 0.92177430 |
| 101 | MP0002067_abnormal_sensory_capabilities | 0.92010924 |
| 102 | MP0008058_abnormal_DNA_repair | 0.90771680 |
| 103 | MP0003635_abnormal_synaptic_transmissio | 0.90182756 |
| 104 | MP0009763_increased_sensitivity_to | 0.90157120 |
| 105 | MP0006138_congestive_heart_failure | 0.89779145 |
| 106 | MP0002938_white_spotting | 0.89675748 |
| 107 | MP0003718_maternal_effect | 0.89455058 |
| 108 | MP0004885_abnormal_endolymph | 0.89432312 |
| 109 | MP0002332_abnormal_exercise_endurance | 0.88854486 |
| 110 | MP0002735_abnormal_chemical_nociception | 0.88442822 |
| 111 | MP0002876_abnormal_thyroid_physiology | 0.88240354 |
| 112 | MP0005084_abnormal_gallbladder_morpholo | 0.87695921 |
| 113 | MP0004147_increased_porphyrin_level | 0.86916136 |
| 114 | MP0005389_reproductive_system_phenotype | 0.86588133 |
| 115 | MP0002557_abnormal_social/conspecific_i | 0.86504532 |
| 116 | MP0002229_neurodegeneration | 0.85175145 |
| 117 | MP0000013_abnormal_adipose_tissue | 0.84513714 |
| 118 | MP0005535_abnormal_body_temperature | 0.84491479 |
| 119 | MP0009642_abnormal_blood_homeostasis | 0.84275696 |
| 120 | MP0005636_abnormal_mineral_homeostasis | 0.82994851 |
| 121 | MP0002063_abnormal_learning/memory/cond | 0.82331810 |
| 122 | MP0002928_abnormal_bile_duct | 0.82135913 |
| 123 | MP0002734_abnormal_mechanical_nocicepti | 0.81096256 |
| 124 | MP0002396_abnormal_hematopoietic_system | 0.80555206 |
| 125 | MP0004484_altered_response_of | 0.79731152 |
| 126 | MP0005075_abnormal_melanosome_morpholog | 0.79687416 |
| 127 | MP0005220_abnormal_exocrine_pancreas | 0.78654234 |
| 128 | MP0002106_abnormal_muscle_physiology | 0.78417079 |
| 129 | MP0001529_abnormal_vocalization | 0.78140680 |
| 130 | MP0000747_muscle_weakness | 0.77171120 |
| 131 | MP0003698_abnormal_male_reproductive | 0.76956572 |
| 132 | MP0003567_abnormal_fetal_cardiomyocyte | 0.76703575 |
| 133 | MP0000230_abnormal_systemic_arterial | 0.70807721 |
| 134 | MP0008874_decreased_physiological_sensi | 0.69866567 |
| 135 | MP0008469_abnormal_protein_level | 0.69520720 |
| 136 | MP0005666_abnormal_adipose_tissue | 0.69289243 |
| 137 | MP0005165_increased_susceptibility_to | 0.69252181 |
| 138 | MP0005646_abnormal_pituitary_gland | 0.62270913 |
| 139 | MP0005448_abnormal_energy_balance | 0.60565182 |
| 140 | MP0000358_abnormal_cell_content/ | 0.60094842 |
| 141 | MP0003953_abnormal_hormone_level | 0.59037711 |
| 142 | MP0003011_delayed_dark_adaptation | 0.59024716 |
| 143 | MP0005334_abnormal_fat_pad | 0.59023636 |
| 144 | MP0000604_amyloidosis | 0.58853294 |
| 145 | MP0003329_amyloid_beta_deposits | 0.57595774 |
| 146 | MP0005369_muscle_phenotype | 0.57540851 |
| 147 | MP0003879_abnormal_hair_cell | 0.56890558 |
| 148 | MP0002971_abnormal_brown_adipose | 0.55139125 |
| 149 | MP0005595_abnormal_vascular_smooth | 0.53130182 |
| 150 | MP0000750_abnormal_muscle_regeneration | 0.52085537 |
| 151 | MP0000759_abnormal_skeletal_muscle | 0.48441629 |
| 152 | MP0001756_abnormal_urination | 0.46952956 |
| 153 | MP0005647_abnormal_sex_gland | 0.43202585 |
| 154 | MP0009764_decreased_sensitivity_to | 0.42796453 |
| 155 | MP0004145_abnormal_muscle_electrophysio | 0.40498367 |
| 156 | MP0002909_abnormal_adrenal_gland | 0.38563958 |
| 157 | MP0001853_heart_inflammation | 0.37498079 |
| 158 | MP0005464_abnormal_platelet_physiology | 0.37364769 |
| 159 | MP0002970_abnormal_white_adipose | 0.35870969 |
| 160 | MP0009672_abnormal_birth_weight | 0.35793718 |
| 161 | MP0001661_extended_life_span | 0.35407663 |
| 162 | MP0000343_altered_response_to | 0.34909737 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.01697908 |
| 2 | Deep venous thrombosis (HP:0002625) | 4.45098906 |
| 3 | Ketosis (HP:0001946) | 4.40375900 |
| 4 | Pancreatic cysts (HP:0001737) | 4.37952250 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 4.36390283 |
| 6 | Ketoacidosis (HP:0001993) | 4.36187093 |
| 7 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.27462808 |
| 8 | Hyperammonemia (HP:0001987) | 4.25223668 |
| 9 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 4.17934156 |
| 10 | Intrahepatic cholestasis (HP:0001406) | 4.03025026 |
| 11 | Ragged-red muscle fibers (HP:0003200) | 3.99182797 |
| 12 | Hypoglycemic coma (HP:0001325) | 3.96613647 |
| 13 | Hyperglycinuria (HP:0003108) | 3.88225029 |
| 14 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.85306637 |
| 15 | Dicarboxylic aciduria (HP:0003215) | 3.85306637 |
| 16 | Pancreatic fibrosis (HP:0100732) | 3.82024676 |
| 17 | Increased serum pyruvate (HP:0003542) | 3.80055111 |
| 18 | Abnormality of glycolysis (HP:0004366) | 3.80055111 |
| 19 | Prolonged partial thromboplastin time (HP:0003645) | 3.78993301 |
| 20 | Hepatic necrosis (HP:0002605) | 3.68452160 |
| 21 | Xanthomatosis (HP:0000991) | 3.61678064 |
| 22 | Congenital stationary night blindness (HP:0007642) | 3.61250843 |
| 23 | True hermaphroditism (HP:0010459) | 3.57143945 |
| 24 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.56454242 |
| 25 | Abnormality of midbrain morphology (HP:0002418) | 3.54942605 |
| 26 | Molar tooth sign on MRI (HP:0002419) | 3.54942605 |
| 27 | Hyperlipoproteinemia (HP:0010980) | 3.54877130 |
| 28 | Cerebral edema (HP:0002181) | 3.51221018 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.45959811 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 3.45959811 |
| 31 | Nephronophthisis (HP:0000090) | 3.36811573 |
| 32 | Hyperglycinemia (HP:0002154) | 3.34371458 |
| 33 | Palpitations (HP:0001962) | 3.32568750 |
| 34 | Acute encephalopathy (HP:0006846) | 3.25319920 |
| 35 | Metabolic acidosis (HP:0001942) | 3.23782361 |
| 36 | Hypolipoproteinemia (HP:0010981) | 3.18642063 |
| 37 | Myoglobinuria (HP:0002913) | 3.18629614 |
| 38 | Hepatocellular necrosis (HP:0001404) | 3.15889651 |
| 39 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.14382559 |
| 40 | Abnormality of alanine metabolism (HP:0010916) | 3.14382559 |
| 41 | Hyperalaninemia (HP:0003348) | 3.14382559 |
| 42 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.10403005 |
| 43 | Lethargy (HP:0001254) | 3.10372437 |
| 44 | Abnormality of serum amino acid levels (HP:0003112) | 3.04108573 |
| 45 | Abnormality of the renal cortex (HP:0011035) | 3.03217629 |
| 46 | Lactic acidosis (HP:0003128) | 2.99460649 |
| 47 | Delayed CNS myelination (HP:0002188) | 2.94650104 |
| 48 | Generalized aminoaciduria (HP:0002909) | 2.93758720 |
| 49 | Type II lissencephaly (HP:0007260) | 2.92222641 |
| 50 | Acute necrotizing encephalopathy (HP:0006965) | 2.91577656 |
| 51 | Abnormality of methionine metabolism (HP:0010901) | 2.89072254 |
| 52 | Abnormality of the renal medulla (HP:0100957) | 2.85804099 |
| 53 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.84129683 |
| 54 | Hyperbilirubinemia (HP:0002904) | 2.80485115 |
| 55 | Cystic liver disease (HP:0006706) | 2.79411137 |
| 56 | Complement deficiency (HP:0004431) | 2.77445032 |
| 57 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.76240842 |
| 58 | Abnormality of the intrinsic pathway (HP:0010989) | 2.74968613 |
| 59 | Increased CSF lactate (HP:0002490) | 2.69565780 |
| 60 | Abnormal drinking behavior (HP:0030082) | 2.67989793 |
| 61 | Polydipsia (HP:0001959) | 2.67989793 |
| 62 | Abnormal biliary tract physiology (HP:0012439) | 2.66399877 |
| 63 | Bile duct proliferation (HP:0001408) | 2.66399877 |
| 64 | Rhabdomyolysis (HP:0003201) | 2.64388167 |
| 65 | Hypoalphalipoproteinemia (HP:0003233) | 2.64187030 |
| 66 | Fair hair (HP:0002286) | 2.62575725 |
| 67 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.59940069 |
| 68 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.59940069 |
| 69 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.55690192 |
| 70 | Congenital, generalized hypertrichosis (HP:0004540) | 2.54450443 |
| 71 | Lipid accumulation in hepatocytes (HP:0006561) | 2.54378157 |
| 72 | Gout (HP:0001997) | 2.53304857 |
| 73 | Chronic hepatic failure (HP:0100626) | 2.52804479 |
| 74 | Vomiting (HP:0002013) | 2.50263273 |
| 75 | Increased muscle lipid content (HP:0009058) | 2.50150407 |
| 76 | Attenuation of retinal blood vessels (HP:0007843) | 2.49900953 |
| 77 | Mitochondrial inheritance (HP:0001427) | 2.49592918 |
| 78 | Medial flaring of the eyebrow (HP:0010747) | 2.48192845 |
| 79 | Exercise-induced myalgia (HP:0003738) | 2.47655163 |
| 80 | Sudden death (HP:0001699) | 2.46470167 |
| 81 | Fat malabsorption (HP:0002630) | 2.46275683 |
| 82 | Epidermoid cyst (HP:0200040) | 2.45519718 |
| 83 | Joint hemorrhage (HP:0005261) | 2.44483149 |
| 84 | Increased serum lactate (HP:0002151) | 2.42743402 |
| 85 | Tubular atrophy (HP:0000092) | 2.42146281 |
| 86 | Absent/shortened dynein arms (HP:0200106) | 2.39499873 |
| 87 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.39499873 |
| 88 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.37132260 |
| 89 | Gaze-evoked nystagmus (HP:0000640) | 2.36836172 |
| 90 | Ventricular tachycardia (HP:0004756) | 2.36772462 |
| 91 | Abolished electroretinogram (ERG) (HP:0000550) | 2.35224297 |
| 92 | Cholelithiasis (HP:0001081) | 2.34179524 |
| 93 | Abnormality of the common coagulation pathway (HP:0010990) | 2.33902738 |
| 94 | Microvesicular hepatic steatosis (HP:0001414) | 2.33607902 |
| 95 | Renal cortical cysts (HP:0000803) | 2.32160432 |
| 96 | Progressive macrocephaly (HP:0004481) | 2.30705854 |
| 97 | Congenital hepatic fibrosis (HP:0002612) | 2.30048486 |
| 98 | Increased hepatocellular lipid droplets (HP:0006565) | 2.29089368 |
| 99 | Late onset (HP:0003584) | 2.28529791 |
| 100 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.27016081 |
| 101 | Abnormal gallbladder morphology (HP:0012437) | 2.26470962 |
| 102 | Methylmalonic acidemia (HP:0002912) | 2.24818385 |
| 103 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.23883476 |
| 104 | Acute hepatic failure (HP:0006554) | 2.22174880 |
| 105 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.20719008 |
| 106 | Calf muscle hypertrophy (HP:0008981) | 2.20154029 |
| 107 | Methylmalonic aciduria (HP:0012120) | 2.18886139 |
| 108 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.18349828 |
| 109 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.18349828 |
| 110 | Right ventricular cardiomyopathy (HP:0011663) | 2.17101572 |
| 111 | Sclerocornea (HP:0000647) | 2.14037683 |
| 112 | Cholecystitis (HP:0001082) | 2.13796495 |
| 113 | Abnormal gallbladder physiology (HP:0012438) | 2.13796495 |
| 114 | Decreased central vision (HP:0007663) | 2.11686279 |
| 115 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.11439054 |
| 116 | Neoplasm of the adrenal gland (HP:0100631) | 2.09578748 |
| 117 | Hypothermia (HP:0002045) | 2.09189791 |
| 118 | Pheochromocytoma (HP:0002666) | 2.08503105 |
| 119 | Inability to walk (HP:0002540) | 2.06995907 |
| 120 | Lipoatrophy (HP:0100578) | 2.06457619 |
| 121 | Increased intramyocellular lipid droplets (HP:0012240) | 2.05799111 |
| 122 | Muscle fiber inclusion bodies (HP:0100299) | 2.02634793 |
| 123 | Skin nodule (HP:0200036) | 2.02219909 |
| 124 | Broad-based gait (HP:0002136) | 2.02137710 |
| 125 | Exercise-induced muscle cramps (HP:0003710) | 2.01801344 |
| 126 | Furrowed tongue (HP:0000221) | 2.01729228 |
| 127 | Sensorimotor neuropathy (HP:0007141) | 2.01392907 |
| 128 | Conjugated hyperbilirubinemia (HP:0002908) | 2.01250783 |
| 129 | Steatorrhea (HP:0002570) | 2.00624888 |
| 130 | Optic disc pallor (HP:0000543) | 1.99499654 |
| 131 | Febrile seizures (HP:0002373) | 1.99148436 |
| 132 | Atrial fibrillation (HP:0005110) | 1.98896484 |
| 133 | Polyuria (HP:0000103) | 1.98236885 |
| 134 | Pendular nystagmus (HP:0012043) | 1.96391807 |
| 135 | Abnormality of urine glucose concentration (HP:0011016) | 1.96332568 |
| 136 | Glycosuria (HP:0003076) | 1.96332568 |
| 137 | CNS demyelination (HP:0007305) | 1.95534193 |
| 138 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.94929353 |
| 139 | Hyperventilation (HP:0002883) | 1.94273478 |
| 140 | Nemaline bodies (HP:0003798) | 1.93541727 |
| 141 | Dilated cardiomyopathy (HP:0001644) | 1.92981992 |
| 142 | Hypoglycemic seizures (HP:0002173) | 1.92931987 |
| 143 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.92887595 |
| 144 | Abnormality of nucleobase metabolism (HP:0010932) | 1.92845501 |
| 145 | Abnormality of secondary sexual hair (HP:0009888) | 1.92356754 |
| 146 | Abnormality of the axillary hair (HP:0100134) | 1.92356754 |
| 147 | Generalized hypopigmentation of hair (HP:0011358) | 1.92231590 |
| 148 | Abnormality of complement system (HP:0005339) | 1.92106737 |
| 149 | Abnormality of purine metabolism (HP:0004352) | 1.91803575 |
| 150 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.90924700 |
| 151 | Neuroendocrine neoplasm (HP:0100634) | 1.90892785 |
| 152 | Supraventricular tachycardia (HP:0004755) | 1.90720779 |
| 153 | Focal motor seizures (HP:0011153) | 1.90080906 |
| 154 | Male pseudohermaphroditism (HP:0000037) | 1.89901814 |
| 155 | Abnormal ciliary motility (HP:0012262) | 1.89869952 |
| 156 | Cerebellar dysplasia (HP:0007033) | 1.89706619 |
| 157 | Asymmetric septal hypertrophy (HP:0001670) | 1.89611343 |
| 158 | Lissencephaly (HP:0001339) | 1.88173595 |
| 159 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.87433513 |
| 160 | 3-Methylglutaconic aciduria (HP:0003535) | 1.86014316 |
| 161 | Progressive inability to walk (HP:0002505) | 1.83039088 |
| 162 | Gait imbalance (HP:0002141) | 1.82637067 |
| 163 | Progressive cerebellar ataxia (HP:0002073) | 1.81140880 |
| 164 | Dry hair (HP:0011359) | 1.80622993 |
| 165 | Stomach cancer (HP:0012126) | 1.79556781 |
| 166 | Severe muscular hypotonia (HP:0006829) | 1.77164650 |
| 167 | Decreased circulating renin level (HP:0003351) | 1.76474574 |
| 168 | Bundle branch block (HP:0011710) | 1.74990801 |
| 169 | Congenital primary aphakia (HP:0007707) | 1.74338793 |
| 170 | Type I transferrin isoform profile (HP:0003642) | 1.73302853 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 6.40350428 |
| 2 | BCKDK | 5.12440011 |
| 3 | FLT3 | 3.97739356 |
| 4 | PIK3CG | 3.01871125 |
| 5 | PDK3 | 2.78840184 |
| 6 | PDK4 | 2.78840184 |
| 7 | ZAK | 2.63871855 |
| 8 | BMPR1B | 2.60667832 |
| 9 | PKN2 | 2.45366148 |
| 10 | MYLK | 2.44096440 |
| 11 | ADRBK2 | 2.41835139 |
| 12 | NUAK1 | 2.41796329 |
| 13 | WNK3 | 2.30172127 |
| 14 | NEK1 | 2.24067161 |
| 15 | CCNB1 | 2.12476987 |
| 16 | FGFR4 | 2.09985188 |
| 17 | GRK1 | 2.09219955 |
| 18 | MAP4K2 | 2.08699925 |
| 19 | ERN1 | 2.08535990 |
| 20 | TLK1 | 2.08141694 |
| 21 | TXK | 1.97769125 |
| 22 | PINK1 | 1.97712899 |
| 23 | PHKG2 | 1.96100602 |
| 24 | PHKG1 | 1.96100602 |
| 25 | KIT | 1.92626441 |
| 26 | SIK3 | 1.89837286 |
| 27 | SIK1 | 1.89327739 |
| 28 | MAP3K12 | 1.83467143 |
| 29 | WNK4 | 1.77232206 |
| 30 | EPHA3 | 1.76075076 |
| 31 | MAPK13 | 1.73797031 |
| 32 | TRIB3 | 1.69672344 |
| 33 | MAP2K7 | 1.68261795 |
| 34 | TAOK2 | 1.67628870 |
| 35 | MAP2K4 | 1.67141352 |
| 36 | STK16 | 1.63590332 |
| 37 | MAPKAPK3 | 1.61914809 |
| 38 | OXSR1 | 1.61400233 |
| 39 | TTN | 1.59049699 |
| 40 | INSRR | 1.58421133 |
| 41 | DAPK1 | 1.47682549 |
| 42 | LMTK2 | 1.46654629 |
| 43 | NTRK3 | 1.39205520 |
| 44 | KDR | 1.37731462 |
| 45 | ARAF | 1.36213332 |
| 46 | EIF2AK1 | 1.31496317 |
| 47 | OBSCN | 1.29894043 |
| 48 | TAOK3 | 1.20873453 |
| 49 | EPHA4 | 1.14376074 |
| 50 | TIE1 | 1.12096960 |
| 51 | TGFBR1 | 1.12037772 |
| 52 | PLK2 | 1.10381437 |
| 53 | BRSK2 | 1.08146382 |
| 54 | MUSK | 1.07223559 |
| 55 | PDK2 | 1.06332700 |
| 56 | STK39 | 1.05476210 |
| 57 | PRPF4B | 1.04920403 |
| 58 | MAPK11 | 1.04095650 |
| 59 | CSF1R | 1.04024234 |
| 60 | VRK2 | 0.99239472 |
| 61 | KSR1 | 0.99052992 |
| 62 | ADRBK1 | 0.98654470 |
| 63 | MAP3K4 | 0.97579476 |
| 64 | MKNK2 | 0.91466015 |
| 65 | BRAF | 0.90853355 |
| 66 | FGFR2 | 0.87866568 |
| 67 | MAP3K7 | 0.87499569 |
| 68 | FES | 0.87293557 |
| 69 | MARK1 | 0.85514734 |
| 70 | MAP3K13 | 0.84661004 |
| 71 | PRKCE | 0.83992359 |
| 72 | MST4 | 0.81783755 |
| 73 | ACVR1B | 0.80915905 |
| 74 | ERBB3 | 0.80819531 |
| 75 | CSNK1G3 | 0.80383252 |
| 76 | MAPK4 | 0.80011895 |
| 77 | EEF2K | 0.79896737 |
| 78 | MAPK12 | 0.79611875 |
| 79 | CSNK1G2 | 0.79496532 |
| 80 | NEK9 | 0.78275633 |
| 81 | MAP3K11 | 0.77304647 |
| 82 | CSNK1A1L | 0.76659222 |
| 83 | MAP2K3 | 0.76367005 |
| 84 | CDK19 | 0.76128837 |
| 85 | GRK6 | 0.75835430 |
| 86 | VRK1 | 0.74230619 |
| 87 | CSNK1G1 | 0.73564569 |
| 88 | TYK2 | 0.73214119 |
| 89 | PAK3 | 0.73170965 |
| 90 | PRKCQ | 0.72158278 |
| 91 | NEK2 | 0.68124449 |
| 92 | SGK2 | 0.66302412 |
| 93 | SIK2 | 0.65881175 |
| 94 | NME1 | 0.65684094 |
| 95 | MAPKAPK5 | 0.65053514 |
| 96 | TNK2 | 0.64876540 |
| 97 | CAMK2A | 0.63593527 |
| 98 | WEE1 | 0.63069266 |
| 99 | TEC | 0.62722213 |
| 100 | MAP3K5 | 0.62531521 |
| 101 | PIK3CA | 0.61418717 |
| 102 | TNIK | 0.60342474 |
| 103 | ITK | 0.59745079 |
| 104 | BRSK1 | 0.57608941 |
| 105 | TRIM28 | 0.57556408 |
| 106 | RAF1 | 0.56765369 |
| 107 | MAP3K6 | 0.56441601 |
| 108 | STK38L | 0.55949604 |
| 109 | PLK4 | 0.55671380 |
| 110 | NME2 | 0.54598856 |
| 111 | MAPK15 | 0.53942342 |
| 112 | RPS6KA5 | 0.53729570 |
| 113 | EIF2AK3 | 0.53635941 |
| 114 | DYRK2 | 0.53331597 |
| 115 | CAMK2D | 0.52848151 |
| 116 | STK11 | 0.51942204 |
| 117 | STK24 | 0.50496443 |
| 118 | PTK2B | 0.50349161 |
| 119 | PRKCG | 0.49553327 |
| 120 | PRKAA1 | 0.49201335 |
| 121 | ABL2 | 0.49054667 |
| 122 | GRK5 | 0.48312948 |
| 123 | PRKAA2 | 0.48220795 |
| 124 | CAMK2G | 0.47102443 |
| 125 | MKNK1 | 0.45323708 |
| 126 | PRKACG | 0.45111828 |
| 127 | ZAP70 | 0.44256599 |
| 128 | GRK7 | 0.43885440 |
| 129 | RPS6KB1 | 0.42806541 |
| 130 | SGK3 | 0.42773392 |
| 131 | SYK | 0.42452624 |
| 132 | PRKG1 | 0.42117589 |
| 133 | DAPK2 | 0.41902534 |
| 134 | CAMKK2 | 0.41557977 |
| 135 | IKBKB | 0.41195537 |
| 136 | CSNK1D | 0.40990925 |
| 137 | AKT3 | 0.40551535 |
| 138 | PKN1 | 0.40221547 |
| 139 | MAP2K6 | 0.40164232 |
| 140 | JAK3 | 0.39576882 |
| 141 | CDK3 | 0.37550141 |
| 142 | PRKCA | 0.37549051 |
| 143 | CAMK4 | 0.34763823 |
| 144 | NTRK2 | 0.34045015 |
| 145 | ERBB4 | 0.34017873 |
| 146 | CSNK1A1 | 0.33897427 |
| 147 | ATR | 0.33225209 |
| 148 | DYRK1A | 0.32276344 |
| 149 | MAP2K1 | 0.31971130 |
| 150 | PRKCI | 0.31669525 |
| 151 | KSR2 | 0.30669392 |
| 152 | IGF1R | 0.30424010 |
| 153 | PRKCZ | 0.29953739 |
| 154 | CASK | 0.29128335 |
| 155 | FER | 0.28600709 |
| 156 | CAMK1 | 0.28587795 |
| 157 | TSSK6 | 0.26999030 |
| 158 | PRKACA | 0.26761275 |
| 159 | MAPK7 | 0.25968725 |
| 160 | RIPK1 | 0.25892868 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.90339262 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.81069202 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.47883719 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.35308218 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.11638963 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.01257051 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.99497978 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.94775430 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.46934481 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.46184322 |
| 11 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.42455802 |
| 12 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.42217648 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.41808359 |
| 14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.31045389 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.30518330 |
| 16 | Carbon metabolism_Homo sapiens_hsa01200 | 2.27426417 |
| 17 | Phototransduction_Homo sapiens_hsa04744 | 2.25613124 |
| 18 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.25433770 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 2.10619417 |
| 20 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.03426751 |
| 21 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.98841845 |
| 22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.97140378 |
| 23 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.84355164 |
| 24 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.77286804 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.72631543 |
| 26 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.70456798 |
| 27 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.67479014 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.67209122 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.65483193 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.60131928 |
| 31 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.59078126 |
| 32 | Homologous recombination_Homo sapiens_hsa03440 | 1.57762084 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.57569828 |
| 34 | Nicotine addiction_Homo sapiens_hsa05033 | 1.54764865 |
| 35 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.50482428 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.46602411 |
| 37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.43288770 |
| 38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.39704567 |
| 39 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.35180546 |
| 40 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.34685686 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30166336 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.28469129 |
| 43 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.27707249 |
| 44 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.26012039 |
| 45 | Parkinsons disease_Homo sapiens_hsa05012 | 1.25835807 |
| 46 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.24710844 |
| 47 | RNA polymerase_Homo sapiens_hsa03020 | 1.23906557 |
| 48 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.23081268 |
| 49 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.22080271 |
| 50 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.22062865 |
| 51 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.20239649 |
| 52 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.20232251 |
| 53 | Olfactory transduction_Homo sapiens_hsa04740 | 1.19864611 |
| 54 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.16510126 |
| 55 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.15368987 |
| 56 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.14339498 |
| 57 | Taste transduction_Homo sapiens_hsa04742 | 1.12834413 |
| 58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.10345759 |
| 59 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.09343846 |
| 60 | Basal transcription factors_Homo sapiens_hsa03022 | 1.04718250 |
| 61 | Asthma_Homo sapiens_hsa05310 | 1.03578529 |
| 62 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.03188026 |
| 63 | Histidine metabolism_Homo sapiens_hsa00340 | 1.00762866 |
| 64 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.00338918 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.98186034 |
| 66 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.96878246 |
| 67 | RNA degradation_Homo sapiens_hsa03018 | 0.95145199 |
| 68 | Sulfur relay system_Homo sapiens_hsa04122 | 0.94677037 |
| 69 | Protein export_Homo sapiens_hsa03060 | 0.88247617 |
| 70 | Morphine addiction_Homo sapiens_hsa05032 | 0.87375375 |
| 71 | Bile secretion_Homo sapiens_hsa04976 | 0.87345463 |
| 72 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.87245055 |
| 73 | Retinol metabolism_Homo sapiens_hsa00830 | 0.86445790 |
| 74 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.86197764 |
| 75 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.84995990 |
| 76 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.84586409 |
| 77 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.82583953 |
| 78 | ABC transporters_Homo sapiens_hsa02010 | 0.79988650 |
| 79 | Circadian entrainment_Homo sapiens_hsa04713 | 0.79595252 |
| 80 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.78197945 |
| 81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.77597279 |
| 82 | Alzheimers disease_Homo sapiens_hsa05010 | 0.75147664 |
| 83 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.73947872 |
| 84 | Insulin secretion_Homo sapiens_hsa04911 | 0.73649282 |
| 85 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.73647383 |
| 86 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.72241612 |
| 87 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.71225424 |
| 88 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.70813671 |
| 89 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.70207466 |
| 90 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.68376503 |
| 91 | Metabolic pathways_Homo sapiens_hsa01100 | 0.67938575 |
| 92 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.67807768 |
| 93 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.67716157 |
| 94 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.67447058 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.66497657 |
| 96 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.63969774 |
| 97 | GABAergic synapse_Homo sapiens_hsa04727 | 0.63697646 |
| 98 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.61643822 |
| 99 | Salivary secretion_Homo sapiens_hsa04970 | 0.61244630 |
| 100 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.59134656 |
| 101 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.58668834 |
| 102 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.58150834 |
| 103 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.53244280 |
| 104 | Huntingtons disease_Homo sapiens_hsa05016 | 0.52954113 |
| 105 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.51757041 |
| 106 | Lysine degradation_Homo sapiens_hsa00310 | 0.51609595 |
| 107 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51040415 |
| 108 | Renin secretion_Homo sapiens_hsa04924 | 0.49216057 |
| 109 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.46645447 |
| 110 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.45771860 |
| 111 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43141352 |
| 112 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.42986155 |
| 113 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.41314713 |
| 114 | Proteasome_Homo sapiens_hsa03050 | 0.40162815 |
| 115 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.39767429 |
| 116 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.39045836 |
| 117 | Insulin resistance_Homo sapiens_hsa04931 | 0.39020563 |
| 118 | Allograft rejection_Homo sapiens_hsa05330 | 0.38911180 |
| 119 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.38161684 |
| 120 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.35574595 |
| 121 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.31273322 |
| 122 | DNA replication_Homo sapiens_hsa03030 | 0.23467044 |
| 123 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.20748564 |
| 124 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.19051329 |
| 125 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18308046 |
| 126 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.17107898 |
| 127 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.15812426 |
| 128 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.13223129 |
| 129 | Purine metabolism_Homo sapiens_hsa00230 | 0.10355727 |
| 130 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.09781772 |
| 131 | Circadian rhythm_Homo sapiens_hsa04710 | 0.08671194 |
| 132 | Base excision repair_Homo sapiens_hsa03410 | 0.07118878 |
| 133 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.05620381 |
| 134 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.04752188 |
| 135 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.01173880 |
| 136 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.00871889 |
| 137 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0790155 |
| 138 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0768035 |
| 139 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0583785 |
| 140 | Prion diseases_Homo sapiens_hsa05020 | -0.0291280 |
| 141 | Mismatch repair_Homo sapiens_hsa03430 | -0.0108707 |
| 142 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.0078643 |

